Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials
- PMID: 14672595
- DOI: 10.1016/s0277-9536(03)00255-7
Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials
Abstract
Randomised controlled trials (RCTs) play a central role in modern medical advance, and they require participants who understand and accept the procedures involved. Published evidence suggests that RCT participants often fail to understand that treatments are allocated at random and that clinicians are in equipoise about which treatment is best. We examine background assumptions that members of the public might draw upon if invited to take part in a RCT. Four studies (N=82; 67; 67; 128), in the UK, identified whether members of the public (i). accept that an individual clinician might be genuinely unsure which of two treatments was better; (ii). judge that when there is uncertainty it is acceptable to suggest deciding at random; (iii). recognise scientific benefits of random allocation to treatment conditions in a trial. Around half the participants were loathe to accept that a clinician could be completely uncertain, and this was no different whether the context was one of individual treatment or research. Most participants found it unacceptable to suggest allocating treatment at random, though there was weak evidence that a research context may reduce the unacceptability. Participants did not judge that more certain knowledge would be gained about which treatment was best when treatments were allocated at random rather than by patient/doctor choice: scientific benefits of randomisation were apparently not recognised. Judgements were no different in non-medical contexts. Results suggest a large mismatch between the assumptions underlying the trial design, and the assumptions that lay participants can bring to bear when they try to make sense of descriptive information about randomisation and equipoise. Previous attempts to improve understanding by improving the clarity or salience of trial information, or of making explicit the research context, while helpful, may need to be supplemented with accessible explanations for random allocation.
Similar articles
-
Lay public's understanding of equipoise and randomisation in randomised controlled trials.Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv. doi: 10.3310/hta9080. Health Technol Assess. 2005. PMID: 15763039
-
Randomisation in trials: do potential trial participants understand it and find it acceptable?J Med Ethics. 2004 Feb;30(1):80-4. doi: 10.1136/jme.2002.001123. J Med Ethics. 2004. PMID: 14872081 Free PMC article.
-
Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial.BMJ. 1998 Oct 31;317(7167):1177-80. doi: 10.1136/bmj.317.7167.1177. BMJ. 1998. PMID: 9794849 Free PMC article. Clinical Trial.
-
Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.J Med Ethics. 1998 Dec;24(6):401-8. doi: 10.1136/jme.24.6.401. J Med Ethics. 1998. PMID: 9873981 Free PMC article. Review.
-
Ethics, randomization, and technology assessment.Cancer. 1994 Nov 1;74(9 Suppl):2653-6. doi: 10.1002/cncr.1994.2820740913. Cancer. 1994. PMID: 7954281 Review.
Cited by
-
Is "rescue" therapy ethical in randomized controlled trials?Pediatr Crit Care Med. 2009 Jul;10(4):431-8. doi: 10.1097/PCC.0b013e318198bd13. Pediatr Crit Care Med. 2009. PMID: 19307815 Free PMC article. Review.
-
Patient advocacy and patient centredness in participant recruitment to randomized-controlled trials: implications for informed consent.Health Expect. 2014 Oct;17(5):670-82. doi: 10.1111/j.1369-7625.2012.00792.x. Epub 2012 Jun 19. Health Expect. 2014. PMID: 22712887 Free PMC article.
-
Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York.JMIR Res Protoc. 2024 Mar 27;13:e56892. doi: 10.2196/56892. JMIR Res Protoc. 2024. PMID: 38536227 Free PMC article.
-
PROMISE (Program Refinements to Optimize Model Impact and Scalability based on Evidence): a cluster-randomised, stepped-wedge trial assessing effectiveness of the revised versus original Ryan White Part A HIV Care Coordination Programme for patients with barriers to treatment in the USA.BMJ Open. 2020 Jul 27;10(7):e034624. doi: 10.1136/bmjopen-2019-034624. BMJ Open. 2020. PMID: 32718922 Free PMC article.
-
The preferences of 600 patients for different descriptions of randomisation.Br J Cancer. 2005 Mar 14;92(5):807-10. doi: 10.1038/sj.bjc.6602445. Br J Cancer. 2005. PMID: 15726098 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical